Skip Over Navigation Links

Contact

TRND Information


TRND News

NIH announces start of clinical trial using cyclodextrin as a potential treatment for Niemann-Pick disease, type C1 — a rare, fatal neurological disorder. The collaborative phase I trial, which stems from pilot work pursued by NCATS' Therapeutics for Rare and Neglected Diseases program, will test the drug in nine patients.


Learn how you can participate in clinical trials - National Institutes of Health